biosimilar

Long term follow-up data from British Association of Dermatologics and Immunomodulators Register (BADBIR) shows safety and effectiveness of SB5 in patients with psoriasis who have started…

How soon after a COVID-19 infection is it OK to administer biologics for patients with…

New York, United States, Aug. 10, 2022 (GLOBE NEWSWIRE) -- An autoinjector is a prefilled syringe with a spring-loaded needle that automatically inserts the needle at the right injection…

The FDA has approved the first interchangeable biosimilar to the ophthalmologic anti-VEGF agent…

Phase 3 study demonstrated clinical equivalence in efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of SB12 compared to reference eculizumab in paroxysmal…

CAMBRIDGE, Mass. and GUANGZHOU, China, June 03, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Bio-Thera Solutions, Ltd. (688177.SH) today presented positive Phase 3 data for…

The FDA approved a higher 2 mg dose of once-weekly injectable semaglutide (Ozempic) for adults…

Delhi, March 29, 2022 (GLOBE NEWSWIRE) -- “US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026” Report Highlights: US Diabetic Drug Market Opportunity: >…

Holds a virtual ceremonial event for the first time to mark the anniversary with its global employees Pledges to keep innovating access to biologic medicines worldwide INCHEON, Korea,…

CAMBRIDGE, Mass and SOLNA, Sweden, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Xbrane Biopharma AB (STO: XBRANE) today announced that they have entered into a…